Signopam en es it fr

Signopam Brand names, Signopam Analogs

Signopam Brand Names Mixture

  • No information avaliable

Signopam Chemical_Formula


Signopam RX_link

Signopam fda sheet

Signopam msds (material safety sheet)

Signopam Synthesis Reference

E. Reeder et al., U.S. Pat. 3,340,253 (1967)

Signopam Molecular Weight

300.739 g/mol

Signopam Melting Point


Signopam H2O Solubility

164 mg/L

Signopam State


Signopam LogP


Signopam Dosage Forms

Capsule (7.5 mg, 15 mg, and 30 mg)

Signopam Indication

For the short-term treatment of insomnia (generally 7-10 days).

Signopam Pharmacology

Temazepam is a benzodiazepine used as a hypnotic agent in the management of insomnia. Temazepam produces CNS depression at limbic, thalamic, and hypothalamic levels of the CNS. Temazepam increases the affinity of the neurotransmitter gamma-aminobutyric acid (GABA) for GABA receptors by binding to benzodiazepine receptors. Results are sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action.

Signopam Absorption

Well absorbed, minimal first-pass metabolism.

Signopam side effects and Toxicity

No information avaliable

Signopam Patient Information

Signopam Organisms Affected

Humans and other mammals